Drimva

AstraZeneca

Associate Director, Distribution Analytics—Cell Therapy

$156K–$233K

US - Gaithersburg - MD · Director · Full-time · Posted Oct 29, 2026

Experience
8+ years in a relevant discipline.
Education
Bachelor's degree in Data Analytics, Supply Chain, Engineering, Computer Science, Statistics, Business Administration, Life Sciences, or a related field.

About the job

Leads distribution analytics and AI-enabled decision support to improve delivery reliability, inventory, logistics, and patient supply across AstraZeneca’s Cell Therapy network.

What you'll do

  • Set the distribution analytics strategy, performance framework, dashboards, predictive tools, and data-governance practices.
  • Develop analytics and AI tools to anticipate distribution risks and guide operational decisions across the supply chain.
  • Lead cross-functional analytics capability, adoption, and performance improvement; present insights and recommendations to senior stakeholders.

What they ask for

  • Bachelor’s degree in a related field.
  • 8+ years of experience in supply chain analytics, distribution analytics, logistics, business intelligence, data science, or a related discipline.
  • Experience developing analytics strategies, dashboards, KPIs, predictive models, or decision-support tools for global supply chain or distribution operations.
  • Experience implementing practical AI or machine-learning use cases in supply chain, logistics, operations, or a comparable business environment.

Nice to have

  • Advanced degree in a related discipline.
  • Experience supporting cell therapy, gene therapy, ATMPs, biologics, vaccines, or other specialized pharmaceutical products.

Pay

$155,516.80 - $233,275.20 USD base salary

Tools

Power BI, Tableau, SQL, Python, R, Excel, SAP

AI focus

Develops predictive and AI-enabled analytics to identify distribution and patient-supply risks, support decisions, and improve operations, with human oversight, transparency, governance, and monitoring.

Model-written summary · the original posting is authoritative

First seen Oct 30, 2026 · Last verified Nov 5, 2026 (UTC)